Selected article for: "drug design and future drug design"

Author: Bilbrey, Jenna; Ward, Logan; Choudhury, Sutanay; Kumar, Neeraj; Sivaraman, Ganesh
Title: Evening the Score: Targeting SARS-CoV-2 Protease Inhibition in Graph Generative Models for Therapeutic Candidates
  • Cord-id: fbyxtlyw
  • Document date: 2021_5_7
  • ID: fbyxtlyw
    Snippet: We examine a pair of graph generative models for the therapeutic design of novel drug candidates targeting SARS-CoV-2 viral proteins. Due to a sense of urgency, we chose well-validated models with unique strengths: an autoencoder that generates molecules with similar structures to a dataset of drugs with anti-SARS activity and a reinforcement learning algorithm that generates highly novel molecules. During generation, we explore optimization toward several design targets to balance druglikeness,
    Document: We examine a pair of graph generative models for the therapeutic design of novel drug candidates targeting SARS-CoV-2 viral proteins. Due to a sense of urgency, we chose well-validated models with unique strengths: an autoencoder that generates molecules with similar structures to a dataset of drugs with anti-SARS activity and a reinforcement learning algorithm that generates highly novel molecules. During generation, we explore optimization toward several design targets to balance druglikeness, synthetic accessability, and anti-SARS activity based on \icfifty. This generative framework\footnote{https://github.com/exalearn/covid-drug-design} will accelerate drug discovery in future pandemics through the high-throughput generation of targeted therapeutic candidates.

    Search related documents:
    Co phrase search for related documents
    • absence presence and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • long cycle and machine learning: 1, 2
    • low similarity and machine learning: 1, 2